Tamarind Health to acquire TalkMed Group for SGD606m.

Tamarind Health, an oncology-focused group, offered to acquire TalkMed Group, a premier provider of medical oncology, for SGD606m. "This partnership is an extraordinary opportunity to improve care for cancer patients. The combined entity opens up opportunities for collaboration within a bigger oncology network. This means improved access to innovative treatments and a wider range of deep medical expertise. Taken together, this will truly transform the way we treat patients, giving them more options and improved outcomes, in line with Singapore’s ambition as a centre of excellence in oncology," Ang Peng Tiam, TalkMed CEO.